Anti-PARK7/DJ1 antibody [MJF-R16 (66-5)] - Oxidized
- RabMAb
- Recombinant
- 각 태그의 뜻
Be the first to review this product! 리뷰 제출
|
(19 제품이 사용된 논문 )
Rabbit Recombinant Monoclonal PARK7/DJ1 antibody. Suitable for WB and reacts with Human samples. Cited in 19 publications.
대체 명칭 보기
Parkinson disease protein 7, Maillard deglycase, Oncogene DJ1, Parkinsonism-associated deglycase, Protein DJ-1, Protein/nucleic acid deglycase DJ-1, DJ-1, PARK7
- WB
Lab
Western blot - Anti-PARK7/DJ1 antibody [MJF-R16 (66-5)] - Oxidized (AB169520)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-PARK7/DJ1 antibody [MJF-R16 (66-5)] - Oxidized (ab169520) at 1/10000 dilution
Lane 1:
Untreated HeLa whole cell lysate at 10 µg
Lane 2:
HeLa whole cell lysate treated with hydrogen peroxide at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 20 kDa
Observed band size: 23 kDa
false
- WB
Collaborator
Western blot - Anti-PARK7/DJ1 antibody [MJF-R16 (66-5)] - Oxidized (AB169520)
ab169520 highlights the presence or absence of the oxidized form of this protein; an antibody directed against total PARK7/DJ1 illustrates the presence of PARK7/DJ1 protein in both lanes.
All lanes:
Western blot - Anti-PARK7/DJ1 antibody [MJF-R16 (66-5)] - Oxidized (ab169520) at 1/1000 dilution
Lane 1:
HeLa cell lysate, untreated at 10 µg
Lane 2:
HeLa cell lysate, treated with hydrogen peroxide at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 20 kDa
false
This image is courtesy of Drs. Un Kang and David White (University of Chicago)
- WB
CiteAb
Western blot - Anti-PARK7/DJ1 antibody [MJF-R16 (66-5)] - Oxidized (AB169520)
PARK7/DJ1 western blot using anti-PARK7/DJ1 antibody [MJF-R16 (66-5)] - Oxidized ab169520. Publication image and figure legend from Wang, X., Williams, D., et al., 2019, Sci Rep, PubMed 31700063.
ab169520 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab169520 please see the product overview.
Preferential binding of DJ-1 to mutant 4RP301L Tau, relative to 4Rwt Tau, in IMR cells. (A) Hierarchical clustering analysis of proteins that exhibited preferential binding to 4RP301L or 4Rwt Tau. (B) Orthogonal confirmation of proteins shortlisted in panel ‘A’ by volcano plot (ANOVA, p = 0.025). Red and green background shading signify preferential binding to 3Rwt/4RP301L Tau and 3Rwt/4Rwt Tau, respectively (fold change greater than 50%). (C) Western blot documenting that the 12 hours induction of wild-type or P301L mutant Tau-EGFP fusion proteins did not alter steady-state levels of DJ-1. Note that in this and subsequent western blot panels samples derived from wild-type human Tau-EGFP expressing cells, P301L mutant Tau-EGFP expressing cells, and EGFP expressing cells are labeled as ‘W in black font’, ‘P’ in blue font and ‘G’ in green font, respectively. (D) Similarly, transgenic overexpression of P301L mutant Tau had no apparent effect on DJ-1 expression levels in 2-year-old mice. Specificity of the anti-DJ-1 antibody was validated with age-matched brain extracts from a DJ-1−/− mouse. (E) Hydrogen peroxide (H2O2) treated IMR cells expressing wild-type or P301L mutant Tau-EGFP fusion proteins exhibited no differences in total DJ-1 levels or of its oxidation at residue C106. As negative and positive controls for oxidized DJ-1 served brain lysates from DJ-1−/− and wild-type mice, respectively, that were subjected to 1 mM H2O2 for 10 min at room temperature. (F) No differences in 4-hydroxy-trans-2-nonenal (4-HNE) levels were observed in IMR cells 12 hrs after induction of wild-type versus P301L mutant Tau. Note that although the expression of the Tau-EGFP fusion proteins altered the bands recognized by the 4-HNE-directed antibody, these signals were not different in cells expressing wild-type versus P301L mutant Tau-EGFP fusions (see Supplementary Fig. S5 for raw data of western blot panels shown in this figure).
false
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-PARK7/DJ1 antibody [MJF-R16 (66-5)] - BSA and Azide free
Reactivity 정보
제품 세부 정보
In recent years, a critical need in the Parkinson's Disease (PD) research community has been access to well-characterized antibodies directed against known PD-relevant proteins. The Michael J. Fox Foundation (MJFF) has supported this effort by partnering with Drs. Un Kang and David White (University of Chicago) to help accelerate PD research.
DJ-1 is widely expressed in the adult mammal and highly conserved between species. Loss-of-function mutations in DJ-1 were recently identified in an autosomal recessive form of Parkinson's disease (PARK7). Among other roles, DJ-1 protects cells against oxidative stress. Oxidization of the cysteine 106 residue (C106) of DJ-1 occurs as a consequence oxidative stress, but is also necessary to fully activate DJ-1 functions. The oxidation state of DJ-1 C106 appears to lead to distinct roles for DJ-1 in the cellular response to oxidative stress. Oxidation of C106 to the sulfinic (-SO2H) form has been implicated as a necessary step to achieve optimal protective functions of DJ-1, whereas oxidation to the sulfonic form (-SO3H) results in the oxidative destabilization of DJ-1 structure. The sulfonic form has been identified as a major oxidized form in PD brains.
With the generation of this critical research tool, MJFF hopes to ensure that the role of this modification can be further investigated by all researchers and the relevance of oxidized forms of DJ-1 can be more definitively examined in Parkinson's disease.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Collaborations
This antibody was developed with support from The Michael J. Fox Foundation.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (19)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Neuromolecular medicine 27:42 PubMed40397198
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecules (Basel, Switzerland) 30: PubMed40363838
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 26: PubMed40332390
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed39273169
2024
Applications
Unspecified application
Species
Unspecified reactive species
Neurotoxicity research 42:28 PubMed38842585
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed38732141
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37958728
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37445771
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 11: PubMed34944489
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2021:5580288 PubMed34211630
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com